105 related articles for article (PubMed ID: 487135)
1. Reduction of substance P levels in the ventral cervical spinal cord of the rat after intracisternal 5,7-dihydroxytryptamine injection.
Singer E; Sperk G; Placheta P; Leeman SE
Brain Res; 1979 Oct; 174(2):362-5. PubMed ID: 487135
[No Abstract] [Full Text] [Related]
2. The effects of monoamine neurotoxins on peptides in the rat spinal cord.
Gilbert RF; Emson PC; Hunt SP; Bennett GW; Marsden CA; Sandberg BE; Steinbusch HW; Verhofstad AA
Neuroscience; 1982 Jan; 7(1):69-87. PubMed ID: 6176903
[TBL] [Abstract][Full Text] [Related]
3. Effect of substance P on the 5,7-dihydroxytryptamine induced alteration of the postnatal development of central serotonin neurons.
Jonsson G; Hallman H
Med Biol; 1983 Apr; 61(2):105-12. PubMed ID: 6192293
[TBL] [Abstract][Full Text] [Related]
4. Early postnatal administration of 5,7-dihydroxytryptamine: effects on substance P and thyrotropin-releasing hormone neurons and terminals in rat brain.
Towle AC; Breese GR; Mueller RA; Hunt R; Lauder JM
Brain Res; 1986 Jan; 363(1):38-46. PubMed ID: 2418913
[TBL] [Abstract][Full Text] [Related]
5. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
Brown LM; Smith DL; Williams GM; Smith DJ
Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting depletion of spinal cord 5-hydroxytryptamine or catecholamines after intraspinal injection of 5,7-dihydroxytryptamine or 6-hydroxydopamine to newborn rats.
Carruba MO; Keller HH; Da Prada M
Neurosci Lett; 1983 Feb; 35(2):173-8. PubMed ID: 6190112
[No Abstract] [Full Text] [Related]
7. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
Hutson PH; Tricklebank MD; Curzon G
Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
[TBL] [Abstract][Full Text] [Related]
8. The effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine on thyrotrophin-releasing hormone in regions of the brain and spinal cord of the rat.
Lighton C; Marsden CA; Bennett GW
Neuropharmacology; 1984 Jan; 23(1):55-60. PubMed ID: 6232468
[TBL] [Abstract][Full Text] [Related]
9. Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine.
Sievers J; Baumgarten HG; Klemm HP; Schlossberger HG; Lolova I
Bibl Anat; 1981; (19):302-7. PubMed ID: 7225075
[No Abstract] [Full Text] [Related]
10. Localization and release of 5-hydroxytryptamine thyrotrophin releasing hormone and substance P in rat ventral spinal cord.
Marsden CA; Bennett GW; Irons J; Gilbert RF; Emson PC
Comp Biochem Physiol C Comp Pharmacol; 1982; 72(2):263-70. PubMed ID: 6183051
[TBL] [Abstract][Full Text] [Related]
11. Effect of selective destruction of serotonergic neurons in nucleus raphe magnus on morphine-induced antinociception.
Mohrland JS; Gebhart GF
Life Sci; 1980 Dec 22-29; 27(25-26):2627-32. PubMed ID: 7219034
[No Abstract] [Full Text] [Related]
12. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
Rodríguez FD; Rodríguez RE
Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
[TBL] [Abstract][Full Text] [Related]
13. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5.7-dihydroxytryptamine injection.
Barbeau H; Bédard P
Neuropharmacology; 1981 May; 20(5):477-81. PubMed ID: 6165921
[No Abstract] [Full Text] [Related]
14. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
Kirby ML; Mattio TG
Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
[TBL] [Abstract][Full Text] [Related]
15. [Effect of 5,7-dihydroxytryptamine on pain sensitivity and analgesic activity of morphine].
Ignatov IuD; Otellin VA; Zaĭtsev AA; Kucherenko RP; Petriaevskaia NV
Biull Eksp Biol Med; 1988 Sep; 106(9):311-4. PubMed ID: 3167183
[TBL] [Abstract][Full Text] [Related]
16. Effect of spinal cord TRH deficiency on lower motorneuron function in the rat.
Van den Bergh P; Kelly JJ; Adelman L; Munsat TL; Jackson IM; Lechan RM
Muscle Nerve; 1987 Jun; 10(5):397-405. PubMed ID: 3112570
[TBL] [Abstract][Full Text] [Related]
17. Selective neurotoxic lesions of descending serotonergic and noradrenergic pathways in the rat.
Berge OG; Fasmer OB; Tveiten L; Hole K
J Neurochem; 1985 Apr; 44(4):1156-61. PubMed ID: 3919157
[TBL] [Abstract][Full Text] [Related]
18. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord.
Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR
Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880
[TBL] [Abstract][Full Text] [Related]
19. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
[TBL] [Abstract][Full Text] [Related]
20. Regeneration of normal terminal innervation patterns by central noradrenergic neurons after 5,7-dihydroxytryptamine-induced axotomy in the adult rat.
Björklund A; Lindvall O
Brain Res; 1979 Aug; 171(2):271-93. PubMed ID: 466444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
